Description:
ICEC-0942 is a small-molecule cyclin-dependent kinase 7 (CDK7) inhibitor developed for cancer therapy. Preclinical study in Acute Myeloid Leukaemia (AML) models shows that ICEC-0942 effectively inhibits the proliferation of several AML cell lines and patient derived AML cells in vitro (IC50 = 0.15-2.6 μM).
- Molecular Weight: 394.52
- Molecular Formula: C22H30N6O
- Application: anticancer drug
Synonyms:
CT7001; CT 7001; CT-7001; ICEC0942; ICEC0 942; ICEC0-942
More details are to be found on supplier website
